Myocardial triglyceride content and epicardial fat mass in human obesity: Relationship to left ventricular function and serum free fatty acid levels

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4689-4695

  Kankaanpää, Mikko ^a   Lehto, Hanna Riikka ^a   Pärkkä, Jussi P ^a   Komu, Markku ^a   Viljanen, Antti ^a   Ferrannini, Ele ^b,c   Knuuti, Juhani ^a   Nuutila, Pirjo ^a   Parkkola, Riitta ^a   Iozzo, Patricia ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b CNR   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; FATTY ACID; LIVER ENZYME; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; EPICARDIUM; FAT CONTENT; FATTY ACID BLOOD LEVEL; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR RESISTANCE; WAIST HIP RATIO;

EID: 33751546348     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0584     Document Type: Article

References (30)

1. Despres JP 2006 Is visceral obesity the cause of the metabolic syndrome? Ann Med. 38:52-63
2. Sharma AM, Chetty VT 2005 Obesity, hypertension and insulin resistance. Acta Diabetol 42(Suppl 1):S3-S8
3. Perseghin G 2005 Muscle lipid metabolism in the metabolic syndrome. Curr Opin Lipidol 16:416-420
4. Santoliquido A, Di Campli C, Miele L, Gabrieli ML, Forgione A, Zocco MA, Lupascu A, Di Giorgio A, Flore R, Pola P, Gasbarrini G, Gasbarrini A, Tondi P, Grieco A 2005 Hepatic steatosis and vascular disease. Eur Rev Med Pharmacol Sci 9:269-271
5. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, Schminke U, Kessler C, John U 2005 Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11:1848-1853
6. Lautamaki R, Borra R, Iozzo P, Komu M, Lehtimaki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P 2006 Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 291:E282-E290
7. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH 2000 Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97:1784-1789
8. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F 2003 Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304-310
9. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F 2003 Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88:5163-5168
10. Carroll JF, Tyagi SC 2005 Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am J Hypertens 18:692-698
11. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG 2003 Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49:417-423
12. 1H-MR spectroscopy of the human heart. Magn Reson Med 42:903-910
13. 1H magnetic resonance spectroscopic imaging. Magn Reson Med 32:175-180
14. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS 2005 Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 289:E935-E939
15. Papavassiliu T, Kuhl HP, Schroder M, Suselbeck T, Bondarenko O, Bohm CK, Beek A, Hofman MM, van Rossum AC 2005 Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging. Radiology 236:57-64
16. Virtanen KA, Hallsten K, Parkkola R, Janatuinen T, Lonnqvist F, Viljanen T, Ronnemaa T, Knuuti J, Huupponen R, Lonnroth P, Nuutila P 2003 Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes 52:283-290
17. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O 1994 Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495
18. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT 1999 Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276:E977-E989
19. Miyamoto M, McClure DE, Schertel ER, Andrews PJ, Jones GA, Pratt JW, Ross P, Myerowitz PD 1998 Effects of hypoproteinemia-induced myocardial edema on left ventricular function. Am J Physiol 274:H937-H944
20. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
21. Ardigo D, Numeroso F, Valtuena S, Franzini L, Piatti PM, Monti L, Delsignore R, Reaven GM, Zavaroni I 2005 Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations. Metabolism 54:1566-1570
22. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F 2004 Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 94:1084-1087
23. Fornes P, Ratel S, Lecomte D 1998 Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an autopsy study of 20 forensic cases. J Forensic Sci 43:777-783
24. Marchington JM, Mattacks CA, Pond CM 1989 Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 94:225-232
25. Iacobellis G, Corradi D, Sharma AM 2005 Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2:536-543
26. Morse SA, Bravo PE, Morse MC, Reisin E 2005 The heart in obesity-hypertension. Expert Rev Cardiovasc Ther 3:647-658
27. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ 2004 Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109:2191-2196
28. Bjorkegren J, Veniant M, Kim SK, Withycombe SK, Wood PA, Hellerstein MK, Neese RA, Young SG 2001 Lipoprotein secretion and triglyceride stores in the heart. J Biol Chem 276:38511-38517
29. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA 2004 Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200-206
30. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K 2004 Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389